<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251029067813N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-11-07</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>Effect of topical Dexamethasone in the dental socket after surgery</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the Effect of Topical Dexamethasone in Alveolar Socket on Pain and Complications After Impacted third molar Tooth Surgery: Clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87174</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this study, participants will be assigned to the intervention and control groups using stratified randomization. Stratification will be performed based on two variables: gender (male and female) and education level (below diploma, diploma, university), resulting in a total of six strata. Within each stratum, participants will be allocated using permuted block randomization with variable block sizes of four and six to maintain balance in the number of participants between the two groups.

The random allocation sequence in each stratum will be generated and recorded by an independent biostatistician (who is not involved in the surgery or outcome assessment) using a table of random numbers and the statistical software International Business Machines Statistical Package for the Social Sciences (version 26). The unit of randomization will be the individual participant.

To ensure allocation concealment, opaque, sealed, and sequentially numbered envelopes will be used. Each envelope will contain a card indicating the assigned treatment group (dexamethasone or placebo). The envelopes will be opened only at the time of surgery by a person who is not involved in the assessment process. Thus, both the participant and the outcome assessor will be blinded to the type of intervention, and the study will be conducted in a double-blind manner. The coded allocation list will be kept by an independent person outside the research team and will be opened only after the completion of data collection, Blinding description: Neither the Patient nor the Evaluator has any information about the type of Treatment assigned to the Subjects. The Code Breaker is also a person outside the Research Team. Written Informed Consent will be obtained from all Patients for participation in the Study as well as for the Surgical Extraction of the Third Molar. However, the Patients will not be informed whether the administered Drug is Dexamethasone or Placebo.</study_design>
      <phase>3</phase>
      <hc_freetext>The socket caused by impacted wisdom tooth surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: local anesthetic injection of inferior alveolar and long buccal nerve block with 2% lidocaine carpol containing epinephrine at 80000:1 will be performed, after which a sulcular incision and creation of a pocket flap will be made to expose the surgical area, and then the impacted wisdom tooth will be extracted. After that, the surgical area will be washed with 100 ml of normal saline, and in the next step, a piece of foam gel is soaked with 4 mg of dexamethasone manufactured by Iran Hormone Pharmaceutical Company and placed in the dental socket, and finally, it will be performed with a 04 nylon suture, then standard drug therapy with acetaminophen will be performed every 6 hours. Intervention 2: Control group: for patients, local anesthesia injection of inferior alveolar and long buccal nerve block with 2% lidocaine carpol containing epinephrine at 80000:1 will be performed, after which a saccular incision and creation of a pocket flap will be made to expose the surgical area, after which the impacted wisdom tooth will be extracted. After that, the surgical area will be washed with 100 ml of normal saline, and in the next step, a piece of foam gel soaked in normal saline will be placed in the socket , then standard drug therapy with acetaminophen will be performed for patients every 6 hours. The normal saline used in this study will be manufactured by Samen Pharmaceutical Company, Mashhad, Iran.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data are backed up in a master file on the Lorestan University server. This file is password-protected and is only accessible to the researchers named in the Human Research Ethics Committee approvals. After the project is completed, identifying data will be removed from the record. These records will be retained permanently to be used if the study is repeated with other drugs in the future. De-identified data may be made available to other researchers in the future to facilitate systematic reviews or meta-analyses. If such data are requested, they will only be made available after review and approval by the Human Research Ethics Committee.

When:
6 Months After Publication of the Results

To whom:
Researchers Affiliated with Academic and Scientific Institutions

Conditions:
For the Completion of Research in the Same Field

Where to obtain:
Zahra.joudakii@gmail.com

How to obtain:
Request from the Human Research Ethics Committee unit of Lorestan University of Medical Sciences and approval from
that unit

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Reza Nadripour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Eram Ave, West goldasht sector</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6814785181</zip>
        <telephone>+98 916 363 1904</telephone>
        <email>Zahra.joudakii@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Nadripour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Eram Ave, West goldasht sector</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6814785181</zip>
        <telephone>+98 916 363 1904</telephone>
        <email>Zahra.joudakii@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged 18 to 25 years
With Impacted third Mandibular Molars
Without Pericoronitis or Infection
Who are not Pregnant
Have no life-threatening Systemic Disease
No Allergy to the Drugs used in the Study
No recent use of Antibiotics or Anti-inflammatory Drugs
Who are willing to participate in the Study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>25 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Those whose Follow-up for recording Pain and Swelling was not possible
Who were unwilling to continue in the Study
Individuals whose Healing process was not normal
Patients who used other Anti-inflammatory Drugs or Antibiotics after Surgery
Whose Impacted third Molars were located close to the Nerve Canal</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: local anesthetic injection of inferior alveolar and long buccal nerve block with 2% lidocaine carpol containing epinephrine at 80000:1 will be performed, after which a sulcular incision and creation of a pocket flap will be made to expose the surgical area, and then the impacted wisdom tooth will be extracted. After that, the surgical area will be washed with 100 ml of normal saline, and in the next step, a piece of foam gel is soaked with 4 mg of dexamethasone manufactured by Iran Hormone Pharmaceutical Company and placed in the dental socket, and finally, it will be performed with a 04 nylon suture, then standard drug therapy with acetaminophen will be performed every 6 hours.</i_keyword>
      <i_keyword>Control group: for patients, local anesthesia injection of inferior alveolar and long buccal nerve block with 2% lidocaine carpol containing epinephrine at 80000:1 will be performed, after which a saccular incision and creation of a pocket flap will be made to expose the surgical area, after which the impacted wisdom tooth will be extracted. After that, the surgical area will be washed with 100 ml of normal saline, and in the next step, a piece of foam gel soaked in normal saline will be placed in the socket , then standard drug therapy with acetaminophen will be performed for patients every 6 hours. The normal saline used in this study will be manufactured by Samen Pharmaceutical Company, Mashhad, Iran.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain severity. Timepoint: The 2nd, 4th, and 7th Days After Surgery. Method of measurement: The Visual Analogue Scale will be used to measure the severity of patients' pain. The patient will be given a ten-centimeter ruler, numbered from 0 to 10, and the patient must indicate the level of pain on it on the second, fourth, and seventh days.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Facial swelling. Timepoint: The 2nd, 4th, and 7th days after surgery. Method of measurement: To measure swelling, we measure from the outer canthus of the eye to the mandibular protuberance, from the middle of the tragus of the ear to the outer corner of the lip on the same side in millimeter.</sec_outcome>
      <sec_outcome>Trismus severity. Timepoint: The 2nd, 4th, and 7th days after surgery. Method of measurement: We measure the distance between the edges of the upper and lower incisors in millimeters.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khoram-Abad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-06</approval_date>
        <contact_name>Lorestan University of Medical Sciences Ethics Committee</contact_name>
        <contact_address>Eram Ave, west Goldasht sector Khorram abad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
